Mike Hennessy Jr.

Featured among the coverage slate in the October issue of Pharmaceutical Executive are deep dives into the long-term implications of new policy-driven overhauls in drug pricing.

Coverage highlights from the September issue of Pharmaceutical Executive offer another example of the accelerated convergence—and future hope—of AI and healthcare.

Spotlighting efforts in precision medicine development, particularly the potential growth of CAR-T therapies in underserved global markets.

Not lost in the mix of June's wide-ranging coverage in Pharmaceutical Executive is an honest take on what guest thought leaders argue is “undoubtedly” the hardest job in biopharma.

Tapping into the reader experience, our new comprehensive survey uncovers valuable input for navigating the changing tides facing pharma decision-makers.

The job of pharma-driven messaging and reputation management may never be more important than it is today.

As coverage in Pharmaceutical Executive’s March issue reinforces, AI's connections and permutations are seemingly touching all parts of the industry—and only growing.

Welcome to a bold new look for Pharmaceutical Executive's print and digital magazine.

Complementing our own industry trends and outlook coverage this month are a trio of diverse crystal-ball perspectives from guest thought leaders.

Developments in the world of artificial intelligence continue to accelerate at a rapid pace. Our November issue of Pharmaceutical Executive explores a few of those that are starting to deliver measurable gains for the industry.

Highlighting two pieces beyond Pharm Exec's October headliners that draw interesting parallels when it comes to life sciences leadership and building teams and capability internally—whether new businesses or new brands.

This month is as good a time as any to take a deep look at the transformations taking place in point-of-care delivery.

Three pieces of coverage in this month’s issue of Pharmaceutical Executive explore the tipping point that's seemingly on the cusp in artificial intelligence.

Our June issue of Pharmaceutical Executive offers a uniquely diverse range of coverage and voices—a "sum-of-its-parts" balance that's not always easy to pull off.

This month, we spotlight the inspiring story of the Healthcare Businesswomen’s Association Woman of the Year, Yvonne Greenstreet.

Efforts to partner and collaborate within the life sciences industry—and externally with governments, regulators, and others—have taken on added weight in recent years.

The new season could bring with it more possibilities for renewal in the biotech sector, as our coverage this month highlights.

Another year in the books.

As conference season ramps up, it's a good time to reflect on the impact advances in pharma have on patients.